MedTrace Logo

Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy

NCT01445717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 358

Last updated 2013-05-03

No results posted yet for this study

Summary

This study evaluates the use of a new method of growing and detecting Group B streptococcus in pregnant women. This new method utilizes sandwiched-membrane petri technology and has the advantage of detecting GBS in less than 6 hours, with less cost, and the potential of allowing antibiotic sensitivities to be performed.

Conditions

  • Streptococcus Infection
  • Pregnancy

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Jonathan Faro, MD · The University of Texas Health Science Center, Houston

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01445717 on ClinicalTrials.gov